Nurs 6630 Final Exam 5
Question i1 0 iout iof i0 ipoints When icompleting ithis iexam, idid iyou icomply iwith iWalden iUniversity’s iCode iof iConduct iincluding ithe iexpectations ifor iacademic iintegrity? Selected iAnswer: Yes • Question i2 1 iout iof i1 ipoints All idrugs ithat ilead ito iaddiction iincrease i__________________in ithe iventral istriatum, iwhich iis ialso icalled ithe i_______________. Selected iAnswer: a. i Dopamine i/ inucleus iaccumbens • Question i3 1 iout iof i1 ipoints A ipatient iwith ichronic iback ipain ihas ibeen iprescribed ia iserotonin-norepinephrine ireuptake iinhibitor i(SNRI). iHow idoes ithe iPMHNP idescribe ithe iaction iof iSNRIs ion ithe iinhibition iof ipain ito ithe ipatient? Selected iAnswer: a. i “The iSNRI ican iincrease inoradrenergic ineurotransmission iin ithe idescending ispinal ipathway ito ithe idorsal ihorn.” • Question i4 1 iout iof i1 ipoints Karen icompletes ithe iEpworth isleepiness iscale iand iscores iabnormally ihigh. iShe iis idiagnosed iwith inarcolepsy. iThe iPMHNP iprescribes ia iwake-promoting iagent ithat iis ia iweak idopamine itransporter iantagonist. iWhich imedication idid ithe iPMHNP iprescribe? Selected iAnswer: a. i Modafanil i(PROVIGIL)
Información del documento
- Subido en
- 23 de febrero de 2022
- Número de páginas
- 14
- Escrito en
- 2019/2020
- Tipo
- Examen
- Contiene
- Preguntas y respuestas
